Ashwagandha Regulation by FSSAI, Rules, Permitted Parts, Safety Concerns

The Food Safety and Standards Authority of India issued an advisory stating that Ashwagandha leaves cannot be used in food products or supplements in any form.

FSSAI Advisory on Ashwagandha

The Food Safety and Standards Authority of India issued an advisory to clarify the permitted use of Ashwagandha in food products and supplements.

• Under the Food Safety and Standards (Health Supplements and Nutraceuticals) Regulations 2016, there is a fixed list of approved plants and their specific parts that can be used in such products.
• According to this list (Schedule IV), only the root of Ashwagandha (Withania somnifera) and its extracts are allowed, and even these must be used within prescribed safety limits.
• The authority observed that some manufacturers were using Ashwagandha leaves and leaf extracts in their products, which is not permitted under the rules.
• Therefore, the advisory clearly states that Ashwagandha leaves cannot be used in any form, whether raw, powdered, or as an extract, in food products or health supplements.
• It directs all Food Business Operators (FBOs) to strictly follow these regulations and stop using unapproved parts of the plant.
• It also warns that any violation will lead to legal action under the Food Safety and Standards Act, 2006.
• Overall, the advisory aims to ensure consumer safety, standardisation, and proper regulation of herbal ingredients in the food and nutraceutical sector.

About Ashwagandha

Ashwagandha (Withania somnifera), also known as Indian ginseng or winter cherry, is a well-known medicinal plant in Ayurveda.

• The term “Ashwagandha” comes from “ashwa” (horse) and “gandha” (smell), indicating strength and the root’s distinct aroma.
• Traditionally classified as a “rasayana” herb, it is believed to promote longevity, improve immunity, and strengthen the nervous system.
• It is widely used for its adaptogenic properties, helping the body cope with stress and restore balance.

‹ ›

Scientific Evidence on Ashwagandha Leaves

Emerging studies suggest that Ashwagandha leaves possess bioactive properties, but their use remains under scientific evaluation.

• Research indicates that leaf extracts contain compounds such as Withaferin D, which may show anti-cancer properties by targeting tumour cells.
• Studies also highlight potential neuroprotective, anti-inflammatory, antimicrobial, cardioprotective, and anti-diabetic effects.
• However, these findings are largely experimental and not yet fully translated into approved food safety standards.